article thumbnail

Atrial arrhythmia and heart failure in congenital heart disease: a pas de deux with consequences

Heart BMJ

In adults with congenital heart disease (ACHD patients), atrial arrhythmias (AA) and heart failure (HF) are common. 1 Factors related to congenital heart disease, such as underlying anatomy, surgical repair technique and scars, can all be considered as AA substrates.

article thumbnail

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

DAIC

6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). Eur J Heart Fail.

article thumbnail

Determinants of survival following heart transplantation in adults with congenital heart disease

Journal of Cardiothoracic Surgery

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.

article thumbnail

Creative concepts article: Potential applications of ultrasound-based leadless endocardial pacing in adult congenital heart disease

HeartRhythm

Cardiac device therapy is frequently required for individuals with adult congenital heart disease (ACHD), whether it be for bradyarrhythmia, ventricular tachyarrhythmia, or cardiac resynchronization therapy (CRT).

article thumbnail

The mechanics of congenital heart disease: from a morphological trait to the functional echocardiographic evaluation

Frontiers in Cardiovascular Medicine

Advances in pediatric cardiac surgery have resulted in a recent growing epidemic of children and young adults with congenital heart diseases (CHDs). In these patients, congenital defects themselves, surgical operations and remaining lesions may alter cardiac anatomy and impact the mechanical performance of both ventricles.

article thumbnail

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

DAIC

mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J. The results from theEKSTROM trial offer powerful evidence thatlow-dose colchicine (0.5 Budoff, M.D.,

article thumbnail

Materialise Acquires FEops to Help Expand Cardiovascular Capabilities

DAIC

The acquisition will allow Materialise to expand its cardiovascular solutions with predictive simulation capabilities, advancing the personalized treatment of patients with heart diseases.

Anatomy 52